Literature DB >> 28592406

Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers.

Susan M Samuel1, Rachel Flynn1, Michael Zappitelli1, Allison Dart1, Rulan Parekh1, Maury Pinsk1, Cherry Mammen1, Andrew Wade1, Shannon D Scott1.   

Abstract

BACKGROUND: Treatment protocols for childhood nephrotic syndrome are highly variable between providers and care centres. We conducted a qualitative study to understand the complex multilevel processes that lead to practice variation and influence provider management of nephrotic syndrome.
METHODS: Focus groups with multidisciplinary pediatric nephrology care providers (n = 67) from 10 Canadian pediatric nephrology centres that had more than 1 pediatric nephrologist were conducted between September 2013 and April 2015. Focus group discussions were guided by the Ottawa Model for Research Use. We used a semistructured interview guide to elicit participants' perspectives regarding 1) the work setting and context of the clinical environment, 2) reasons for variation at the provider level and 3) clinical practice guidelines for nephrotic syndrome. Focus group discussions were transcribed and analyzed concurrently with the use of qualitative content analysis.
RESULTS: Emerging themes were grouped into 2 categories: centre-level factors and provider-level factors. At the centre level, the type of care model used, clinic structures and resources, and lack of communication and collaboration within and between Canadian centres influenced care variation. At the provider level, use of experiential knowledge versus empirical knowledge and interpretation of patient characteristics influenced provider management of nephrotic syndrome.
INTERPRETATION: Centre- and provider-level factors play an important role in shaping practice differences in the management of childhood nephrotic syndrome. Further research is needed to determine whether variation in care is associated with disparities in outcomes. Copyright 2017, Joule Inc. or its licensors.

Entities:  

Year:  2017        PMID: 28592406      PMCID: PMC5498309          DOI: 10.9778/cmajo.20160078

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  15 in total

1.  Mindful practice.

Authors:  R M Epstein
Journal:  JAMA       Date:  1999-09-01       Impact factor: 56.272

2.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

3.  Focus group research and "the patient's view".

Authors:  Pascale Lehoux; Blake Poland; Genevieve Daudelin
Journal:  Soc Sci Med       Date:  2006-06-23       Impact factor: 4.634

4.  Court reporters: a viable solution for the challenges of focus group data collection?

Authors:  Shannon D Scott; Heather Sharpe; Kathy O'Leary; Ulrike Dehaeck; Kathryn Hindmarsh; John Garry Moore; Martin H Osmond
Journal:  Qual Health Res       Date:  2009-01

5.  From mindless to mindful practice--cognitive bias and clinical decision making.

Authors:  Pat Croskerry
Journal:  N Engl J Med       Date:  2013-06-27       Impact factor: 91.245

Review 6.  Rare childhood diseases: how should we respond?

Authors:  Y Zurynski; K Frith; H Leonard; E Elliott
Journal:  Arch Dis Child       Date:  2008-08-06       Impact factor: 3.791

Review 7.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

8.  Management of childhood onset nephrotic syndrome.

Authors:  Debbie S Gipson; Susan F Massengill; Lynne Yao; Shashi Nagaraj; William E Smoyer; John D Mahan; Delbert Wigfall; Paul Miles; Leslie Powell; Jen-Jar Lin; Howard Trachtman; Larry A Greenbaum
Journal:  Pediatrics       Date:  2009-07-27       Impact factor: 7.124

Review 9.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  E M Hodson; N S Willis; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality.

Authors:  Andrea Pasini; Gabriella Aceto; Anita Ammenti; Gianluigi Ardissino; Vitalba Azzolina; Alberto Bettinelli; Elena Cama; Sante Cantatore; Antonella Crisafi; Giovanni Conti; Maria D'Agostino; Alessandra Dozza; Alberto Edefonti; Carmelo Fede; Elena Groppali; Chiara Gualeni; Alessandra Lavacchini; Marta Lepore; Silvio Maringhini; Paola Mariotti; Marco Materassi; Francesca Mencarelli; Giovanni Messina; Amata Negri; Marina Piepoli; Fiammetta Ravaglia; Angela Simoni; Laura Spagnoletta; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2014-08-17       Impact factor: 3.714

View more
  7 in total

1.  Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?

Authors:  Matthew Sibley; Abishek Roshan; Alanoud Alshami; Marisa Catapang; Jasper J Jöbsis; Trevor Kwok; Nonnie Polderman; Jennifer Sibley; Douglas G Matsell; Cherry Mammen
Journal:  Pediatr Nephrol       Date:  2018-05-22       Impact factor: 3.714

2.  Clinical significance of T lymphocyte subsets, immunoglobulin and complement expression in peripheral blood of children with steroid-dependent nephrotic syndrome/frequently relapsing nephrotic syndrome.

Authors:  Shulian Chen; Jianxin Wang; Shishan Liang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Reverse Phenotyping after Whole-Exome Sequencing in Steroid-Resistant Nephrotic Syndrome.

Authors:  Samuela Landini; Benedetta Mazzinghi; Francesca Becherucci; Marco Allinovi; Aldesia Provenzano; Viviana Palazzo; Fiammetta Ravaglia; Rosangela Artuso; Emanuele Bosi; Stefano Stagi; Giulia Sansavini; Francesco Guzzi; Luigi Cirillo; Augusto Vaglio; Luisa Murer; Licia Peruzzi; Andrea Pasini; Marco Materassi; Rosa Maria Roperto; Hans-Joachim Anders; Mario Rotondi; Sabrina Rita Giglio; Paola Romagnani
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-12       Impact factor: 8.237

4.  The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures.

Authors:  Susan M Samuel; Allison Dart; Guido Filler; Martin Bitzan; Maury Pinsk; Cherry Mammen; Alberto Nettel-Aguirre; Maneka A Perinpanayagam; Tomoko Takano; Rahul Chanchlani; Michael Zappitelli
Journal:  BMC Nephrol       Date:  2019-05-14       Impact factor: 2.388

Review 5.  Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions.

Authors:  Ashlene M McKay; Rulan S Parekh; Damien Noone
Journal:  Pediatr Nephrol       Date:  2022-04-28       Impact factor: 3.651

Review 6.  Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome.

Authors:  Anne M Schijvens; Rob Ter Heine; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714

7.  Commentary on "Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short version of the updated German Best Practice Guideline (S2e)".

Authors:  Rasmus Ehren; Marcus R Benz; Paul T Brinkkötter; Jörg Dötsch; Wolfgang R Eberl; Jutta Gellermann; Peter F Hoyer; Isabelle Jordans; Clemens Kamrath; Markus J Kemper; Kay Latta; Dominik Müller; Jun Oh; Burkhard Tönshoff; Stefanie Weber; Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2021-06-05       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.